Recipharm, a leading contract development and manufacturing organisation (CDMO), announced an exclusive licence and collaboration agreement with Medspray and Resyca, to develop soft mist nasal ...
ENGLEWOOD CLIFFS, NJ, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company”), a developmental stage biopharmaceutical company focused on merging traditional ...
MedSpray® is a novel transdermal and topical drug delivery tool that can be used to deliver drugs in extended release form via spray-on-films delivered to the skin or other mucosal (topical) membranes ...
Please provide your email address to receive an email when new articles are posted on . A new licensing agreement between Silo Pharma and Medspray Pharma BV allows SPC-15, Silo’s therapeutic for PTSD, ...
SARASOTA, FL, July 18, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and ...
GUILDFORD, England--(BUSINESS WIRE)--MedPharm Ltd (www.medpharm.co.uk), the topical drug development specialist, today announced it has been granted a series of further patents for its novel MedSpray® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results